Abstract
Stimulator of interferon genes (STING) is an essential adaptor in the cytosolic DNA-sensing innate immune pathway1. STING is activated by cyclic GMP–AMP (cGAMP) produced by the DNA sensor cGAMP synthase (cGAS)2,3,4,5. cGAMP-induced high-order oligomerization and translocation of STING from the endoplasmic reticulum to the Golgi and post-Golgi vesicles are critical for STING activation6,7,8,9,10,11. Other studies have shown that phosphatidylinositol phosphates (PtdInsPs) and cholesterol also have important roles in STING activation, but the underlying mechanisms remain unclear12,13,14,15,16,17. Here we demonstrate that cGAMP-induced high-order oligomerization of STING is enhanced strongly by phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2 and PtdIns(4,5)P2, and by PtdIns4P to a lesser extent. Our cryo-electron microscopy structures reveal that PtdInsPs together with cholesterol bind at the interface between STING dimers, directly promoting the high-order oligomerization. The structures also provide an explanation for the preference of the STING oligomer to different PtdInsPs. Mutational and biochemical analyses confirm the binding modes of PtdInsPs and cholesterol and their roles in STING activation. Our findings shed light on the regulatory mechanisms of STING mediated by specific lipids, which may underlie the role of intracellular trafficking in dictating STING signalling.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Data availability
The coordinates and cryo-EM maps of the structures reported in the study have been deposited in the RCSB and EMD databases, respectively, under the following accession codes: 9DAN and EMD-46694 (STING–cGAMP–STG2–PtdIns(4,5)P2), 9DAT and EMD-46697 (STING–cGAMP–STG2–PtdIns(3,5)P2), 9DAV and EMD-46699 (STING–cGAMP–STG2–PtdIns4P) and 9DAW and EMD-46700 (STING–cGAMP–C53–PtdIns(3,5)P2), EMD-71619 (STING–cGAMP–PtdIns(3,5)P2). No atomic model was built for the STING–cGAMP–PtdIns(3,5)P2 dataset owing to the low resolution of the map.
References
Zhang, X., Bai, X. C. & Chen, Z. J. Structures and mechanisms in the cGAS-STING innate immunity pathway. Immunity 53, 43–53 (2020).
Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826–830 (2013).
Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786–791 (2013).
Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792 (2009).
Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674–678 (2008).
Zhao, B. et al. A conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1. Nature 569, 718–722 (2019).
Zhang, C. et al. Structural basis of STING binding with and phosphorylation by TBK1. Nature 567, 394–398 (2019).
Lu, D. et al. Activation of STING by targeting a pocket in the transmembrane domain. Nature 604, 557–562 (2022).
Li, J. et al. Activation of human STING by a molecular glue-like compound. Nat. Chem. Biol. 20, 365–372 (2024).
Ergun, S. L., Fernandez, D., Weiss, T. M. & Li, L. STING polymer structure reveals mechanisms for activation, hyperactivation, and inhibition. Cell 178, 290–301 (2019).
Shang, G., Zhang, C., Chen, Z. J., Bai, X. C. & Zhang, X. Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP. Nature 567, 389–393 (2019).
Luteijn, R. D. et al. The activation of the adaptor protein STING depends on its interactions with the phospholipid PI4P. Sci. Signal. 17, eade3643 (2024).
Ford, I. et al. Defining STING–sterol interactions with chemoproteomics. RSC Chem. Biol. 6, 1451–1464 (2025).
Kemmoku, H. et al. Single-molecule localization microscopy reveals STING clustering at the trans-Golgi network through palmitoylation-dependent accumulation of cholesterol. Nat. Commun. 15, 220 (2024).
Takahashi, K. et al. A cell-free assay implicates a role of sphingomyelin and cholesterol in STING phosphorylation. Sci. Rep. 11, 11996 (2021).
York, A. G. et al. Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling. Cell 163, 1716–1729 (2015).
Tan, J. X. et al. PtdIns(3,5)P2 is an endogenous ligand of STING in innate immune signaling. Nature https://doi.org/10.1038/s41586-025-10084-0 (2026).
Hong, C. et al. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature 607, 366–373 (2022).
Li, J. et al. Non-cell-autonomous cancer progression from chromosomal instability. Nature 620, 1080–1088 (2023).
Hu, J. et al. STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma. Nature 616, 806–813 (2023).
Lu, C. et al. DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity. Cancer Cell 39, 96–108 (2021).
Gulen, M. F. et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374–380 (2023).
Liu, Y. et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371, 507–518 (2014).
Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).
Saitoh, T. et al. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl Acad. Sci. USA 106, 20842–20846 (2009).
Dobbs, N. et al. STING activation by translocation from the ER is associated with infection and autoinflammatory disease. Cell Host Microbe 18, 157–168 (2015).
Mukai, K. et al. Homeostatic regulation of STING by retrograde membrane traffic to the ER. Nat. Commun. 12, 61 (2021).
Deng, Z. et al. A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome. J. Exp. Med. 217, e20201045 (2020).
Triantafilou, M. et al. Human rhinovirus promotes STING trafficking to replication organelles to promote viral replication. Nat. Commun. 13, 1406 (2022).
McKnight, K. L. et al. Stimulator of interferon genes (STING) is an essential proviral host factor for human rhinovirus species A and C. Proc. Natl Acad. Sci. USA 117, 27598–27607 (2020).
Fang, R., Jiang, Q., Jia, X. & Jiang, Z. ARMH3-mediated recruitment of PI4KB directs Golgi-to-endosome trafficking and activation of the antiviral effector STING. Immunity 56, 500–515 (2023).
Pryde, D. C. et al. The discovery of potent small molecule activators of human STING. Eur. J. Med. Chem. 209, 112869 (2020).
Shirey, C. M., Scott, J. L. & Stahelin, R. V. Notes and tips for improving quality of lipid-protein overlay assays. Anal. Biochem. 516, 9–12 (2017).
DeRouchey, J., Hoover, B. & Rau, D. C. A comparison of DNA compaction by arginine and lysine peptides: a physical basis for arginine rich protamines. Biochemistry 52, 3000–3009 (2013).
Schink, K. O., Tan, K. W. & Stenmark, H. Phosphoinositides in control of membrane dynamics. Annu. Rev. Cell Dev. Biol. 32, 143–171 (2016).
Mesmin, B. et al. A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP. Cell 155, 830–843 (2013).
Godi, A. et al. ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat. Cell Biol. 1, 280–287 (1999).
Srikanth, S. et al. The Ca2+ sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum. Nat. Immunol. 20, 152–162 (2019).
Zhang, B. C. et al. Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds. Nat. Commun. 15, 2760 (2024).
Yi, G. et al. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. PLoS ONE 8, e77846 (2013).
Ruiz-Moreno, J. S. et al. The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires’ disease in humans. PLoS Pathog. 14, e1006829 (2018).
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).
Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169–4185 (2021).
Wagner, T. et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. 2, 218 (2019).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861–877 (2019).
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D 74, 519–530 (2018).
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Acknowledgements
Cryo-EM data were collected at the University of Texas Southwestern Medical Center (UTSW) Cryo-Electron Microscopy Facility, funded in part by the Cancer Prevention and Research Institute of Texas (CPRIT) Core Facility Support Award RP220582. We thank D. Stoddard and J. Martinez Diaz for facility access; the members of the Structural Biology Laboratory at UTSW for equipment use; and M. Miletto for data collection. A portion of this research was supported by NIH grant U24GM129547 and performed at the PNCC at OHSU and accessed through EMSL (grid.436923.9), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research. This work is supported in part by grants from the National Institutes of Health (R35GM150506 to J.X.T.; R01-AI093967 to Z.J.C.; R01CA273595 to X.Z. and X.-c.B.; and R01CA299257 to Z.J.C., X.Z. and X.-c.B.), the Welch foundation (I-1389 to Z.J.C., I-1702 to X.Z. and I-1944 to X.-c.B.) and the Cancer Grand Challenge (CGCFUL-2021\100007) with support from Cancer Research UK and the US National Cancer Institute (to Z.J.C.). X.-c.B. and X.Z. are Virginia Murchison Linthicum Scholars in Medical Research at UTSW. Z.J.C. is a Howard Hughes Medical Institute (HHMI) investigator.
Author information
Authors and Affiliations
Contributions
X.-c.B. and X.Z. designed the study with input from J.L.; J.L. prepared protein samples for cryo-EM. X.Z. and X.-c.B. performed cryo-EM data acquisition and structure determination. J.L. performed the biochemistry experiments and cell-based assays. X.-c.B., X.Z. and J.L. analysed data. X.-c.B., X.Z., Z.J.C. and J.X.T. supervised the work and obtained funding. X.-c.B. and X.Z. wrote the initial draft. All of the authors contributed to the final draft.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature thanks John Burke, Søren Paludan and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data figures and tables
Extended Data Fig. 1 PIPs enhance the high-order oligomerization of STING to different extents.
(a) Analyses of the high-order oligomerization of STING treated with various concentration of PI(3,5)P2 and PI(4,5)P2 by native PAGE. The image shown here is a representative of three biological repeats. (b) Cryo-EM micrographs showing high-order oligomers of STING bound to different combinations of agonists and PIPs. cGAMP and STG2 induced relatively short oligomers of STING. Different PIPs promoted the formation of longer oligomers to different extents. The micrographs are representative images from more than 5,000 distinct regions. The scale bar is 500 Å.
Extended Data Fig. 2 Image processing procedure for the cryo-EM structure of STING bound to cGAMP/PI(3,5)P2/STG2 and the quality of the structure.
(a) Image processing procedure. (b) Gold-standard FSC curve of the final 3D reconstruction (left) and FSC between the map and atomic model (right). (c) Local resolution map of the final 3D reconstruction. (d) Sample densities of various parts of the structure.
Extended Data Fig. 3 Image processing procedure for the cryo-EM structure of STING bound to cGAMP/PI(4,5)P2/STG2 and the quality of the structure.
(a) Image processing procedure. (b) Gold-standard FSC curve of the final 3D reconstruction (left) and FSC between the map and atomic model (right). (c) Local resolution map of the final 3D reconstruction. (d) Sample densities of various parts of the structure.
Extended Data Fig. 4 Image processing procedure for the cryo-EM structure of STING bound to cGAMP/PI4P/STG2 and the quality of the structure.
(a) Image processing procedure. (b) Gold-standard FSC curve of the final 3D reconstruction (left) and FSC between the map and atomic model (right). (c) Local resolution map of the final 3D reconstruction. (d) Sample densities of various parts of the structure.
Extended Data Fig. 5 Comparison of the binding sites of different PIPs.
(a) Cryo-EM map and atomic model of the STING high-order oligomer in the presence of cGAMP, PI4P and STG2. PI4P and CHS have very weak density and therefore not included in the atomic model. (b) Comparison of the density of PIPs in the four structures presented in this study. The thresholds of the cryo-EM maps were set such that the sidechain of H16 is covered at similar levels in the four structures. It is clear that the density for PI4P is much weaker than PI(3,5)P2 and PI(4,5)P2 in the three other structures.
Extended Data Fig. 6 Image processing procedure for the cryo-EM structure of STING bound to cGAMP/PI(3,5)P2/C53 and the quality of the structure.
(a) Image processing procedure. (b) Gold-standard FSC curve of the final 3D reconstruction (left) and FSC between the map and atomic model (right). (c) Local resolution map of the final 3D reconstruction. (d) Sample densities of various parts of the structure. (e) Detailed view of the binding modes of PI(3,5)P2 and CHS at the interface between two STING dimers in the structure of STING bound to cGAMP/PI(3,5)P2/C53. (f) Cryo-EM density of PI(3,5)P2 and CHS in the structure of STING bound to cGAMP/PI(3,5)P2/C53.
Extended Data Fig. 8 Lipid binding assay for purified STING.
(a) Binding of wild-type STING to a panel of lipids in a lipid-strip assay. (b) Binding of wild-type STING to an array of cholesterol and derivatives. (c) Comparison of binding to PIPs between wild-type STING and the K20E/R71H mutant. (d) Comparison of cholesterol binding between wild-type STING and the S80I mutant. The data shown are representative of three biological repeats.
Extended Data Fig. 9 Cholesterol may bind to STING without PIPs.
(a) The size exclusion chromatography profiles of wild-type STING and S80I mutant. The profile of the S80I mutant is similar to that of the wild type, suggesting that the S80I mutant is properly folded. (b) Cryo-EM map and atomic model of STING oligomer determined without PIPs (EMD-29282).
Supplementary information
Supplementary Information
Supplementary Figs. 1–5 (uncropped gels for the Figures and Extended Data Figures).
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, J., Tan, J.X., Chen, Z.J. et al. Regulation of STING activation by phosphoinositide and cholesterol. Nature (2026). https://doi.org/10.1038/s41586-025-10076-0
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41586-025-10076-0